Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
XBIO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
XBIO
Xenetic Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
XBIO
Xenetic Biosciences, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
XBIO
with
LLY
No shared trading history for XBIO and LLY.
Shared co-movers: not yet measured (XBIO).
XBIO, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
XBIO
Xenetic Biosciences, Inc.
Change
1.91
▼
−4.98%
· post 1.77
Mkt cap
$4.4M
Revenue
$660,601
Q2 FY26
Revenue
$3M
FY25
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
XBIO
Xenetic Biosciences, Inc.
vs
LLY
ELI Lilly & Co
1.91
▼
−4.98%
post 1.77
Price
1,360.90
▼
−0.28%
post 1,358.90
$4.4M
Mkt cap
$1.2T
Q2 FY26
$660,601
Revenue
$24.4B
Q3 FY26
FY25
$3M
Revenue
$65.2B
FY25
Change
Change
XBIO
1.91
▼
−4.98%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26